Table 1.
Group | Compound | Developmental stage |
References |
---|---|---|---|
HGF/c-Met antagonists | NK4 | Preclinical | (57, 58) |
Uncleavable HGF | Preclinical | (59) | |
Sema | Preclinical | (60) | |
Decoy Met | Preclinical | (61) | |
Recombinant variant Met | Preclinical | (62) | |
Antibodies against HGF | L2G7 (Galaxy Biotech) | Preclinical | (63) |
AMG102 (Amgen) | Phase II | (64) | |
Antibodies against HGF | OA-5D5 (Genentech) | Preclinical | (65) |
CE-355621 (Pfizer) | Preclinical | (66) | |
DN30 (Metheresis) | Preclinical | (67) |